CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with Osteoporosis
In-Jin Cho, Ho-Yeon Chung, Sung-Woon Kim, Jae-Won Lee, Tae-Won Lee, Hye-Soon Kim, Sin-Gon Kim, Han Seok Choi, Sung-Hee Choi, Chan Soo Shin, Ki-Won Oh, Yong-Ki Min, Jung-Min Koh, Yumie Rhee, Dong-Won Byun, Yoon-Sok Chung, Jeong Hyun Park, Dong Jin Chung, Minho Shong, Eun-Gyoung Hong, Chang Beom Lee, Ki Hyun Baek, Moo-Il Kang
Endocrinol Metab. 2015;30(3):272-279.   Published online December 9, 2014
DOI: https://doi.org/10.3803/EnM.2015.30.3.272

Excel Download

Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with Osteoporosis
Endocrinology and Metabolism. 2015;30(3):272   Crossref logo
Link1 Link2 Link3

A monthly combined agent of ibandronate and cholecalciferol is effective in bone metabolism but not in muscle strength and bone mineral density in Korean postmenopausal women with osteoporosis
Maturitas. 2017;100:158   Crossref logo
Link1 Link2

Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women
International Journal of Rheumatic Diseases. 2009;12(3):216-224   Crossref logo
Link1 Link2

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
Yearbook of Endocrinology. 2007;2007:331-333   Crossref logo
Link1 Link2

Compliance, persistence and patient satisfaction in 150 mg once-monthly oral ibandronate treated patients with postmenopausal osteoporosis — A non-interventional study
Bone. 2009;44:S433   Crossref logo
Link1 Link2

Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women
Archives of Osteoporosis. 2017;12(1):   Crossref logo
Link1 Link2 Link3

Abstract #314: Once-Monthly Ibandronate in Postmenopausal Osteoporosis: Two-Year Efficacy and Safety Data from MOBILE
Endocrine Practice. 2006;12:45   Crossref logo
Link1 Link2

Early changes in 25-hydroxyvitamin D levelsand bone markers after monthly risedronatewith cholecalciferol in Korean patients with osteoporosis
Clinical Interventions in Aging. 2013;597   Crossref logo
Link1

Once-monthly Ibandronate for postmenopausal Osteoporosis: Review of a new dosing regimen
Clinical Therapeutics. 2006;28(4):475-490   Crossref logo
Link1 Link2

Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis
Bone. 2010;46(6):1626-1632   Crossref logo
Link1 Link2